"Breast Carcinoma In Situ" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition in which abnormal cells have not spread outside the duct, lobule, or nipple to other tissues of the breast. There are 3 types of breast carcinoma in situ: DUCTAL CARCINOMA IN SITU; LOBULAR CARCINOMA IN SITU; and PAGET DISEASE OF THE NIPPLE
| Descriptor ID |
D000071960
|
| MeSH Number(s) |
C04.557.470.200.240.187 C04.588.180.130 C17.800.090.500.130
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Breast Carcinoma In Situ".
Below are MeSH descriptors whose meaning is more specific than "Breast Carcinoma In Situ".
This graph shows the total number of publications written about "Breast Carcinoma In Situ" by people in this website by year, and whether "Breast Carcinoma In Situ" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Breast Carcinoma In Situ" by people in Profiles.
-
Lobular Carcinoma In Situ Incidentally Detected by Dual-Energy Computed Tomography Balkan Med J. 2022 05 24; 39(3):218-219.
-
Assessment of MRI-detected lesions on screening tomosynthesis in patients with newly diagnosed breast cancer. Clin Imaging. 2020 Jan; 59(1):50-55.
-
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2ß. Lab Invest. 2018 01; 98(1):117-129.